4.25 USD
▼-0.25-5.56%
盘后 4.41 +3.76%
2026-09-15
市值
$414.20M
市盈率
—
EPS
-2.18
股息率
—
52 周区间
4.22 – 13.15
成交量
2.78M
Beta
1.00
目标价
22.50
52W 低 4.2252W 高 13.15
价格走势
公司简介
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.